Skip to content

R&D at other companies

Coherent logo
CoherentCOHR
$185.99M+23.4%
Keysight Technologies logo
Keysight TechnologiesKEYS
$320M+28.0%
Fortive logo
FortiveFTV
$66.5M+3.9%
Ciena logo
CienaCIEN
$237.91M+10.7%
Amkor Technology logo
Amkor TechnologyAMKR
$41.76M-8.5%
Onto Innovation logo
Onto InnovationONTO
$35.1M+25.2%

Other financials

Income statement

See full
Revenue$406.8M+42.8%
Gross profit$234.1M+45.7%
Operating income$24.8M+192%
Net income$6.4M-67.2%
EPS (diluted)$0.03-66.7%

Balance sheet

See full
Cash & equivalents$499.0M+33.4%
Total debt$286.6M+2.5%
Total equity$846.5M+16.1%
Total assets$2.5B+30.8%

Cash flow

See full
Operating cash flow$42.5M-4.9%
CapEx$5.9M-13.2%
Free cash flow$36.9M+1.1%

Valuation

See full
Market cap$11.64B+210%
Enterprise value$11.42B+213%
P/S8.5×+4.9×

Profitability

See full
Gross margin56.9%-0.8pp
Operating margin4.3%
Net margin-4%-4.5pp
FCF margin6.3%-1.8pp

Returns & leverage

See full
Return on equity-7%-7.7pp
Debt / equity0.3×0.0×
Current ratio1.6×+0.1×

Where this comes from

Reported directly by Viavi Solutions Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Viavi Solutions Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viavi Solutions Inc.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viavi Solutions Inc.'s R&D?
Viavi Solutions Inc. (VIAV) reported R&D of $71M in Q1 2026.
How has Viavi Solutions Inc.'s R&D changed year-over-year?
Viavi Solutions Inc.'s R&D increased by 42.0% year-over-year, from $50M to $71M.
What is the long-term trend for Viavi Solutions Inc.'s R&D?
Over 4 years (2021 to 2025), Viavi Solutions Inc.'s R&D has grown at a 0.7% compound annual growth rate (CAGR), from $203M to $208.7M.
What does R&D mean?
Spending on creating new products or improving existing technology.
How do you interpret R&D?
High spending signals a commitment to long-term innovation, while low spending may indicate a focus on short-term profitability at the expense of future growth.
How does R&D compare across companies?
High for tech and pharma; low for mature, non-innovative industries.